Bavarian Nordic A/S (ADR)
General ticker "BVNRY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.3B (TTM average)
Bavarian Nordic A/S (ADR) follows the US Stock Market performance with the rate: 45.3%.
Estimated limits based on current volatility of 0.5%: low 9.75$, high 9.86$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.52$, 15.11$]
- 2025-12-31 to 2026-12-31 estimated range: [9.39$, 16.43$]
Financial Metrics affecting the BVNRY estimates:
- Positive: with PPE of 15.2 at the end of fiscal year the price was very low
- Positive: 7.86 < Operating profit margin, % of 16.44
- Positive: 6.82 < Operating cash flow per share per price, % of 13.07
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.42 > 6.04
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 79.19 > 63.39
- Positive: -14.38 < Investing cash flow per share per price, % of -12.54
- Negative: Industry earnings per price (median), % of -16.34 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term BVNRY quotes
Long-term BVNRY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | DKK3,150.79MM | DKK7,062.34MM | DKK5,716.21MM |
| Operating Expenses | DKK3,154.64MM | DKK5,564.82MM | DKK4,776.44MM |
| Operating Income | DKK-3.85MM | DKK1,497.52MM | DKK939.77MM |
| Non-Operating Income | DKK-327.77MM | DKK-14.58MM | DKK31.59MM |
| Interest Expense | DKK119.69MM | DKK105.52MM | DKK77.87MM |
| R&D Expense | DKK1,183.09MM | DKK2,228.08MM | DKK862.51MM |
| Income(Loss) | DKK-331.61MM | DKK1,482.94MM | DKK971.36MM |
| Taxes | DKK15.77MM | DKK7.75MM | DKK-16.62MM |
| Profit(Loss)* | DKK-347.38MM | DKK1,475.19MM | DKK987.98MM |
| Stockholders Equity | DKK7,149.99MM | DKK10,339.93MM | DKK11,408.56MM |
| Inventory | DKK919.07MM | DKK1,643.74MM | DKK2,327.31MM |
| Assets | DKK12,391.25MM | DKK14,353.21MM | DKK14,405.86MM |
| Operating Cash Flow | DKK220.05MM | DKK1,119.21MM | DKK1,949.83MM |
| Capital expenditure | DKK1,381.58MM | DKK977.40MM | DKK1,687.64MM |
| Investing Cash Flow | DKK-877.40MM | DKK-945.56MM | DKK-1,870.86MM |
| Financing Cash Flow | DKK635.82MM | DKK735.83MM | DKK55.77MM |
| Earnings Per Share** | DKK-1.64 | DKK6.41 | DKK4.20 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.